Previous 10 | Next 10 |
2024-04-20 12:03:00 ET Summary abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield of 11.3% and exposure to diverse subsectors of the healthcare industry. The fund outperforms its peers, abrdn World Healthcare Fund (THW) and BlackRock's Health Sciences Trust (BM...
2024-04-20 09:53:05 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-04-20 07:00:00 ET Summary Focusing on consistent dividend growth can lead to higher returns in lower-risk areas. The portfolio emphasizes companies with wide-moat business models, strong financials, and a commitment to shareholder returns. Blending higher-yielding dividen...
2024-04-20 07:00:00 ET Summary Volatility in the stock market is normal and healthy, with average yearly gains of 22% in positive years and average peak intra-year declines of -14%. Dividend aristocrats, which have lower volatility than the overall market, can be a good investment...
2024-04-19 15:00:19 ET More on the markets S&P 500: Positive Outlook, I'm Modifying My Hedge SPY: Resurgent Inflation, Soaring Yields, Geopolitical Turmoil - 1970s All Over Again? SPY: Sell Signals Caused By War Uncertainty (Technical Analysis Downgrade) ...
2024-04-19 12:49:52 ET More on Dow, Johnson & Johnson, etc. Johnson & Johnson: Buy This Bargain Before It's Gone Kenvue: Fairly Valued Spinout Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript Johnson & Johnson wins trial over talc-rela...
2024-04-19 11:51:54 ET More on Johnson & Johnson Johnson & Johnson: Buy This Bargain Before It's Gone Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript Johnson & Johnson 2024 Q1 - Results - Earnings Call Presentation Dividend Roundup: J...
2024-04-19 11:40:00 ET Summary Mayar Capital provides investment management services to institutions, family offices, and high net-worth individuals. For the three months ending March 31, 2024, the Mayar Responsible Global Equity Fund (Class A) was up 4.31% net of all expenses and...
2024-04-19 08:13:02 ET More on Dividends What Investors Need To Know About Dividend Cuts A $1.5 Million Inflation-Resistant Portfolio For Retiring With Dividends 3 Upcoming Dividend Increases, Including A Dividend King Boost Your Dividend Income With These Tw...
2024-04-19 06:13:03 ET More on Bristol-Myers Squibb, Gilead, etc. Johnson & Johnson: Buy This Bargain Before It's Gone Bristol-Myers Squibb: Market Pessimism Won't Last Forever Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript FDA approves Alvo...
News, Short Squeeze, Breakout and More Instantly...
Thursday, Johnson & Johnson (NYSE:JNJ) agreed to acquire Proteologix Inc., a privately held biotechnology company focused o...
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a...
Acquisition advances Johnson & Johnson’s leading Dermatology portfolio with opportunity to address significant unmet need in atopic dermatitis (AD) Includes bispecific antibodies targeting proven disease pathways and offers the potential to provide best-in-disease therapeutics ...